References
- Brown, A., Kumar, S., Tchounwou, P.B. (2019). Cisplatin-based chemotherapy of human cancers. J Cancer Sci Ther. 11(4): 97.
- Hanigan, M.H., Devarajan, P. (2003). Cisplatin nephrotoxicity: molecular mechanisms. Cancer Ther. 1, 47-61.
- Shikole, E., Gjorgoski, I., Glavas Dodov, M., Kocheva, N., Trojachanec, J., Zafirov, D. (2022). The effect of Coenzyme Q10 in cisplatin induced myelosuppression in rats. Maced Pharm Bull. 68 (Suppl. 1): 385-386. https://doi.org/10.33320/maced.pharm.bull.2022.68.03.186
- Ramesh, G., Reeves, W.B. (2002). TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 110(6): 835-842. https://doi.org/10.1172/JCI200215606 PMid:12235115 PMCid:PMC151130
- Zhang, B., Ramesh, G., Norbury, C.C., Reeves, W.B. (2007). Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-α produced by renal parenchymal cells. Kidney Int. 72(1): 37-44. https://doi.org/10.1038/sj.ki.5002242 PMid:17396112
- Tripathi, P., Alshahrani, S. (2021). Mitigation of IL-1β, IL-6, TNF-α, and markers of apoptosis by ursolic acid against cisplatin-induced oxidative stress and nephrotoxicity in rats. Hum Exp Toxicol. 40(12_Suppl.): S397-S405. https://doi.org/10.1177/09603271211045953 PMid:34569348
- Lee, S., Kim, W., Moon, S.-O., Sung, M.J., Kim, D.H., Kang, K.P., Jang, Y.B., Lee, J.E., Jang, K.Y., Park, S.K. (2006). Rosiglitazone ameliorates cisplatin-induced renal injury in mice. Nephrol Dial Transplant. 21(8): 2096-2105. https://doi.org/10.1093/ndt/gfl194 PMid:16728429
- Aupperle, K.R., Bennett, B.L., Boyle, D.L., Tak, P.P., Manning, A.M., Firestein, G.S., (1999). NF-kappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol. 163(1): 427-433. https://doi.org/10.4049/jimmunol.163.1.427 PMid:10384145
- Alhusaini, A., Fadda, L., Albogami, L., Alnaim, N., Sarawi, W., Mattar, D., Hasan, I., (2022). Liposomal coenzyme Q10 abates inflammation, apoptosis and DNA damage induced by an overdose of paracetamol in rat’s liver. J King Saud Univ-Sci. 34(6): 102144. https://doi.org/10.1016/j.jksus.2022.102144
- Celik, B., Sağıroğlu, A.A., Özdemir, S. (2017). Design, optimization and characterization of coenzyme Q10- and D-panthenyl triacetate-loaded liposomes. Int J Nanomedicine. 12, 4869-4878. https://doi.org/10.2147/IJN.S140835 PMid:28744121 PMCid:PMC5511013
- Fouad, A.A., Al-Sultan, A.I., Refaie, S.M., Yacoubi, M.T. (2010). Coenzyme Q10 treatment ameliorates acute cisplatin nephrotoxicity in mice. Toxicology 274(1-3): 49-56. https://doi.org/10.1016/j.tox.2010.05.007 PMid:20510337
- Fatima, S., Al-Mohaimeed, N., Al-Shaikh, Y., Tyagi, P., Banu, N., Hasan, S., Arjumand, S. (2016). Combined treatment of epigallocatechin gallate and Coenzyme Q10 attenuates cisplatin-induced nephrotoxicity via suppression of oxidative/nitrosative stress, inf lammation and cellular damage. Food Chem Toxicol. 94, 213-220. https://doi.org/10.1016/j.fct.2016.05.023 PMid:27265264
- Mohamed, H.A., Said, R.S. (2021). Coenzyme Q10 attenuates inflammation and fibrosis implicated in radiation enteropathy through suppression of NF-kB/TGF-β/MMP-9 pathways. Int Immunopharmacol. 92, 107347. https://doi.org/10.1016/j.intimp.2020.107347 PMid:33418245
- McRae, M.P. (2023). Coenzyme Q10 supplementation in reducing inflammation: an umbrella review. J Chiropr Med. 22(2): 131-137. https://doi.org/10.1016/j.jcm.2022.07.001 PMid:37346240 PMCid:PMC10280088
- Li, H., Chen, F. (2017). Preparation and quality evaluation of coenzyme Q10 long-circulating liposomes. Saudi J Biol Sci. 24(4): 797-802. https://doi.org/10.1016/j.sjbs.2015.10.025 PMid:28490948 PMCid:PMC5415142
- Shalabalija, D., Mihailova, L., Crcarevska, M.S., Karanfilova, I.C., Ivanovski, V., Nestorovska, A.K., Novotni, G., Dodov, M.G. (2021). Formulation and optimization of bioinspired rosemary extract loaded PEGylated nanoliposomes for potential treatment of Alzheimer’s disease using design of experiments. J Drug Deliv Sci Technol. 63, 102434. https://doi.org/10.1016/j.jddst.2021.102434
- Dinarello, C.A. (2000). Proinflammatory cytokines. Chest 118(2): 503-508. https://doi.org/10.1378/chest.118.2.503 PMid:10936147
- Semenzato, G. (1990). Tumour necrosis factor: a cytokine with multiple biological activities. Br J Cancer. 61(3): 354-361. https://doi.org/10.1038/bjc.1990.78 PMid:2183871 PMCid:PMC1971301
- Grace, P.A. (1994). Ischaemia-reperfusion injury. Br J Surg. 81(5): 637-647. https://doi.org/10.1002/bjs.1800810504 PMid:8044536
- Peng, J., Ma, J., Zhang, L., Lu, B. (2020). Coenzyme Q10 attenuates airway inflammation and oxidative stress in neonatal asthmatic rats. Trop J Pharm Res. 19(9): 1969-1975. https://doi.org/10.4314/tjpr.v19i9.24
- Al-Megrin, W.A., Soliman, D., Kassab, R.B., Metwally, D.M., Moneim, A.E.A. El-Khadragy, M.F. (2020). Coenzyme Q10 activates the antioxidant machinery and inhibits the inflammatory and apoptotic cascades against lead acetate-induced renal injury in rats. Front Physiol. 11, 64. https://doi.org/10.3389/fphys.2020.00064 PMid:32116774 PMCid:PMC7020615
- Mantle, D., Heaton, R.A., Hargreaves, I.P. (2021). Coenzyme Q10 and immune function: an overview. Antioxidants (Basel). 10(5): 759. https://doi.org/10.3390/antiox10050759 PMid:34064686 PMCid:PMC8150987
- Pastor-Maldonado, C.J., Suárez-Rivero, J.M., Povea-Cabello, S., Álvarez-Córdoba, M., Villalón-García, I., Munuera-Cabeza, M., Suárez-Carrillo, A., et al. (2020). Coenzyme Q10: novel formulations and medical trends. Int J Mol Sci. 21(22): 8432. https://doi.org/10.3390/ijms21228432 PMid:33182646 PMCid:PMC7697799
- Zhang, Y. (2019). A review of the delivery system of coenzyme-Q10 based on nanotechnology. IOP Conf Series: Earth and Environ Sci. 242(4): 042003. https://doi.org/10.1088/1755-1315/242/4/042003